Russia to cooperate with China on production of Sputnik V vaccine chinadaily.com.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chinadaily.com.cn Daily Mail and Mail on Sunday newspapers.
2021-05-09 18:57 By: Xinhua
Photo taken on April 28, 2021 shows the COVID-19 vaccines Sputnik V in Moscow, Russia. [Photo/Xinhua]
MOSCOW - The Russian Direct Investment Fund (RDIF) has signed deals with three Chinese biopharmaceutical companies for the production of over 260 million doses of its Sputnik V vaccine against the coronavirus in the past weeks, according to statements published on the website of the RDIF.
The first contract was signed with China s Shenzhen Yuanxing Gene-tech Co., Ltd. on March 29 for the production of over 60 million doses of the Sputnik V jab that is scheduled to start this month.
Another agreement was reached on April 1 with a subsidiary of a key leader in the pharmaceutical field, the Tibet Rhodiola Pharmaceutical Holding, namely TopRidge Pharma, for the production of over 100 million doses per year.
2021-05-07 15:35:20 GMT2021-05-07 23:35:20(Beijing Time) Xinhua English
Photo taken on April 28, 2021 shows the COVID-19 vaccines "Sputnik V" in Moscow, Russia. (Xinhua/Evgeny Sinitsyn)
MOSCOW, May 7 (Xinhua) The Russian Direct Investment Fund (RDIF) has signed deals with three Chinese biopharmaceutical companies for the production of over 260 million doses of its Sputnik V vaccine against the coronavirus in the past weeks, according to statements published on the website of the RDIF.
The first contract was signed with China s Shenzhen Yuanxing Gene-tech Co., Ltd. on March 29 for the production of over 60 million doses of the Sputnik V jab that is scheduled to start this month.
Russia to cooperate with China on production of Sputnik V vaccine
Xinhua
08 May 2021, 02:05 GMT+10
MOSCOW, May 7 (Xinhua) The Russian Direct Investment Fund (RDIF) has signed deals with three Chinese biopharmaceutical companies for the production of over 260 million doses of its Sputnik V vaccine against the coronavirus in the past weeks, according to statements published on the website of the RDIF. The first contract was signed with China s Shenzhen Yuanxing Gene-tech Co., Ltd. on March 29 for the production of over 60 million doses of the Sputnik V jab that is scheduled to start this month. Another agreement was reached on April 1 with a subsidiary of a key leader in the pharmaceutical field, the Tibet Rhodiola Pharmaceutical Holding, namely TopRidge Pharma, for the production of over 100 million doses per year.
Chinese firms agree to manufacture Russia s Sputnik V vaccine upi.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from upi.com Daily Mail and Mail on Sunday newspapers.